Company profile

inHEART, SAS

inHEART, SAS has 1 AI-enabled medical device on the FDA list. The first decision was on February 29, 2024 and the most recent on February 29, 2024 (inHEART Models). Its most common review panel is Radiology (1 device).

1AI devices
2024First decision
2024Latest decision
1Specialties

Timeline

  1. inHEART Models · Radiology · QIH